Astrocytoma (Amut-IDH,G3-4), in which mutations in the ATRX (3/5 Patients), TP53 (4/5 Patients) and CDKN2A/B (1/5 Patients). This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).